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The precursors of peptide hormones that possess a COOH-terminal a-amide group contain a glycine 
residue following the amino acid which is amidated in the hormone. <Glu-His-Pro-Gly was synthesized 
as a putative precursor of thyroliberin. Bovine pituitary neurosecretory granuies were shown to contain 
an amide group-forming activity associated with an tw, of about 62000 protein(s) which converts the 
tetrapeptide to thyroliberin. 
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1. INTRODUCTION 
Many peptide hormones contain a COOH- 
terminal amino acid m-amide residue. Thus, the 
terminal residue in oxytocin, vasopressin, and 
luliberin is glycinamide; in calcitonin and 
thyroliberin it is prolinamide; secretin and CY- 
melanotropin terminate in vahnamide; and gastrin 
terminates in phenylalanine amide. The details of 
COOH-terminal amidation of the peptide hor- 
mones are not fully understood. Recently, it was 
shown [2] that porcine pituitary neurosecretory 
granules contain an enzyme that converts the syn- 
thetic tripeptide, D-Tyr-Val-Gly, to D- 
Tyr-Val-CONH2. The mechanism involved 
dehydrogenation and hydrolysis of the glycine- 
cont~ning peptide. Amidation also occurred when 
valine in position 2 was replaced by either 
phenylalanine or glycine. A COOH-terminal 
glycine was, however, mandatory. The authors 
proposed that a similar mechanism may be involv- 
ed in the amidation of peptide hormones in tissues 
and that the COOH-terminal glycine may serve as 
a signal for amidation of the residue preceding it. 
Consistent with this proposal is the finding that in 
several of the hormone precursor molecules, the 
residue which is amidated in the hormone is usual- 
ly followed by glycine (thus, for example, the 
precursors of ~-melanotropin [3] and the honeybee 
hormone, mellitin [4], and the putative precursors 
of vasopressin [5] and calcitonin [6,7]). 
Our report describes the partial purification of 
an enzyme activity from bovine pituitary 
neurosecretory granules that converts 
<Glu-His-Pro-Gly to <Glu-His-Pro-CONHz 
(thyrotropin-releasing factor or thyroliberin). The 
tetrapeptide was synthesized and used with the ex- 
pectation that thyrotropin precursors molecules, in 
analogy to the examples cited above, will contain 
a glycine residue following the hormone sequence. 
2. MATERIALS AND METHODS 
Abbreviations: The abbreviations used for amino acids 
and peptide hormones follow the recommendations of 
the IUPAC-IUB Commission on Biochemical 
Nomenclature (11 
Thyroliberin and glycine ethyl ester were pur- 
chased from Sigma. Deamido-thyroliberin 
(<Glu-His-Pro) was obtained from Bachem, CA. 
[Pro-2,3-“HlThyroliberin (21.8 Ci/mmol) was 
purchased from New England Nuclear. Bovine 
brain thyroliberin deamidase (spec. act. 440 
units/mg) was purified as in [8]. 
<Glu-His-Pro-Gly was synthesized by coupl- 
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ing deamido-thyroliberin with glycine ethyl ester 
using the N,N’-dicy~lohexylcarbodiimide method 
[8,9]. The peptide was purified by subjecting ali- 
quots of the synthetic material to high- 
performance liquid chromatography (HPLC) on a 
Supelcosil LC-8 column (IS x 0.46 cm) eluted with 
0.1070 trifluoroacetic acid-0.2% acetonitrile. Ap- 
propriate fractions (see fig.3A) were collected, 
lyophilized, and dissolved in water. The purity and 
concentration of the tetrapeptide was determined 
by hydrolysis of an aliquot in vacua in 6 N HCl at 
105°C for 20 h followed by amino acid analysis us- 
ing a Durrum model D-500 analyzer. Glu, His, 
Pro, and Gly were the only amino acids detected; 
the relative amounts of each were: 0.99, 1.0, 0.97 
and 0.99, respectively. 
[3H]Deamido-thyroliberin was made as follows: 
[3H]thyroliberin, 50 /cm01 (stock [3H]thyroliberin 
was mixed with unlabeled thyroliberin to give a 
final spec. act. of about 2000 
counts. min-’ . nmol-‘), was incubated at 37°C for 
20 h in a solution (2 ml) containing 0.01 M K- 
phosphate buffer (pH 7.5), 1 mM EDTA, 5 mM 
dithiothreitol, and 2opg of thyroliberin 
deamidase. The solution was then applied to a 
Whatman 3 MM paper (20 x 60 cm) and subjected 
to high-voltage paper electrophoresis in 
pyridine/acetic acid/water (0.5 : 5 :94.5), pH 3.5 
[S]. The area corresponding to deamido- 
thyroliberin (detected by spraying a 0.5 cm wide 
strip of the paper with Pauly reagent) was cut out 
and eluted in water. An aliquot was taken for 
hydrolysis and amino acid analysis. The remaining 
solution was lyophilized and used for the synthesis 
of [3H]<Glu-His-Pro-G1y. The product was 
purified by HPLC as described above (yield, about 
12fimol of the tetrapeptide; 1400 
counts. min-’ . nmol-I). 
Thin-layer chromatography (TLC) of the pep- 
tides was carried out on silica gel-coated plastic 
sheets (Brinkman) developed in 
chloroform/methanol/30% ammonia (125 :75 : 25) 
[S]. The peptides were detected by spraying with 
Pauly reagent. The Rf-values for thyroliberin, 
deamido-thyroliberin, and <Glu-His-Pro-Gly in 
this system were 0.60, 0.40 and 0.28, respectively 
(fig. 1). 
Fresh, iced bovine pituitaries were obtained 
from a local supplier. A particulate fraction con- 
taining the neurose~retory granules was prepared 
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Fig.1. Thin-layer chromatography of thyroliberin 
(TRF), deamido-thyroliberin (TRF-OH), and <Glu-- 
His-Pro-Cly (TRF-Gly) on a silica-coated plastic sheet. 
The arrow indicates point of sample application (5 nmol 
each). 
as follows [IO]: the pituitaries were homogenized 
(at 4*C) in 8 volumes (w/v) of 0.01 M sodium 
phosphate buffer (pH 7) containing 0.3 M sucrose 
using a Potter-Elvehjem homogenizer (Teflon pes- 
tle). The homogenate was centrifuged at 750 x g 
for 3 min; the rotor speed was then increased to 
10000 x g and the centrifugation continued for 
10 min. The supernatant hus obtained was cen- 
trifuged at 25000 x g for 20 min. The pellet was 
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suspended in 0.02 M sodium phosphate buffer (pH 
7) containing 0.15 M NaCl (phosphate-NaCl) and 
recentrifuged at 25000 x g for 20 min. The pellet 
was finally suspended in phosphate-NaCl buffer 
(1 ml/4 g of tissue) (granule fraction). Acetone 
powder of the granule fraction was made as 
follows: acetone (precooled to - 15°C; 10 
volumes) was added dropwise to the stirred granule 
fraction, The precipitate was filtered on a Buchner 
funnel and washed with several volumes of 
acetone. The dried powder was stored at - 15°C. 
An extract of the acetone powder was prepared by 
homogenizing the powder in 10 volumes of 
phosphate-NaCl. The mixture was stirred at 4°C 
for 1 h and then centrifuged at 10000 x g for 
20 min (supernatant = acetone powder extract). 
Thyroliberin synthesis was studied as follows: 
the reaction mixture (SO pl), in general, contained 
2.5 ~1 of 2 mM 3H-labeled <Glu-His-Pro-Gly 
(final concentration, 0.1 mM), 7.Spl of 
phosphate-NaCl buffer, and 40~1 of either the 
neurosecretory granule fraction or its acetone 
powder extract. The incubations were carried out 
at 37°C (2-24 h) in 1.5 ml stoppered microfuge 
tubes under an atmosphere of 02. Controls were 
simultaneously run in which the peptide and the 
tissue preparation were separately omitted. The 
reactants were analyzed either by TLC or by 
HPLC. For TLC, the reactions were terminated by 
the addition of SO ~1 of 0.1 N HCl and the solution 
applied to a Dowex SO-H+ column (200-400 mesh; 
0.5 x 1 cm). The column was washed with 5 ml of 
0.1 N WC1 and then eluted with 3 ml of 2 N HCl. 
The eluates were evaporated to dryness and the 
residue dissolved in 50~1 of water containing 
SO nmol of unlabeled thyroliberin (added as a car- 
rier). The sample was subjected to TLC as describ- 
ed above. Areas corresponding to thyroliberin 
were cut out and radioactivity determined in a li- 
quid scintillation counter using toluene-based 
medium. For HPLC, the reactions were ter- 
minated by placing the tubes in a boiling-water 
bath for 2 min. Denatured proteins were removed 
by centrifugation and lo-20 ~1 of the supernatant 
subjected to HPLC as described above. 
3. RESULTS AND DISCUSSION 
Thyroliberin is found in several regions of the 
brain, the highest levels being in the hypothalamus 
[ 1 l] . Thyroliberin-degrading activities are also pre- 
sent in the brain and these have hampered studies 
on its biosynthesis [8,12,13]. Our preliminary 
studies showed that bovine pituitary homogenates 
were significantly less active in degrading 
thyroliberin than the extracts of other brain 
regions. Pituitary also synthesizes hormones (e.g., 
cu-melanotropin) which contain COOH-terminal 
amide groups. Assuming that amidating enzyme(s) 
exhibit broad specificity towards peptide 
substrates, we chose pituitary for our studies on 
the synthesis of the amide group of thyroliberin. 
The tetrapeptide, <Glu-His-Pro-Gly, was syn- 
thesized as a putative precursor for the hormone. 
Its purity was established by HPLC (see fig.3), 
thin-layer chromatography (fig. l), and amino acid 
analysis. 
Detectable amounts (by HPLC) of thyroliberin 
were formed upon incubation of the tetrapeptide 
with bovine pituitary extracts. Deamido- 
thyroliberin was also detected (this can be produc- 
ed from either the tetrapeptide or thyroliberin by 
the action of post-proline cleaving enzymes [S]). In 
agreement with previous reports [2], the amide 
group-forming activity was recovered in the 
neurosecretory granule fraction. About 75% of the 
activity was lost upon storage of the granule frac- 
tion at 4°C for 48 h. Further studies showed that 
the amidating activity was retained in acetone 
powder of the granule fraction. Storage of the 
acetone powder at - 15°C for up to 4 weeks was 
without significant effect on the activity. 
Partial purification of amidating activity was 
achieved by gel-filtration (fig.2). In the experiment 
shown, 23 units of thyroliberin-forming activity 
(see fig.2 legend for definition of the unit) were ap- 
plied to the column. Comparison of the elution 
profile of the amidating enzyme with those for 
proteins of known M, (Mr calibration kit obtained 
from Scharz-Mann), indicated that the activity is 
associated with protein (or proteins) of 1M, = 
60-65000 (peak fraction volume corresponds to 
M, = 62000). About 155 units of amidating activi- 
ty were recovered in fractions 61-70. This increase 
in total activity upon gel-filtration is probably due 
to its separation from thyroliberin-degrading en- 
zymes. Post-proline cleaving activity is still evident 
in fractions 62 and 64 as seen from the appearance 
of deamido-thyroliberin (fig.3B and C). The spec. 
act. in fraction 62 was about 39 (nmol of 
279 
Volume 152. number 2 FEBS LETTERS February 1983 
- % 1.2- 
;; l.O- 
cz 
3 0.8- 
6 
0.6 - 
8 
Ei 
a 0.4- 
$ 
Q 0.2- 
-if- 
30 40 50 60 70 80 90 100 
Fraction number 
Fig.2. Partial purification of the amidating activity from 
bovine pituitary. An extract made from 225 mg of 
acetone powder prepared from the neurosecretory 
granule fraction of pituitaries was subjected to gel 
filtration on Ultrogel AcA34 (LKB) column (1.6 x 
85 cm), equilibrated and eluted with phosphate-NaC1 
buffer (1.5 ml/fraction). A unit of amidating enzyme 
activity is the amount of enzyme that forms 1 nmol of 
thyroliberin (TRF) from <Glu-His-Pro-Gly per 24 h 
(see section 2 for assay procedure). ThyroIiberin was 
determined by HPLC (see fig.3). 
thyroliberin formed. mg protein-*. 24 h-l), a 
49-fold increase over that seen in the acetone 
powder extract. 
Use of [3H]Pro-labeled tetrapeptide followed by 
TLC of the reaction products confirmed the for- 
mation of 3H-labeled thyroliberin. The 3H-labeled 
product was isolated by HPLC, lyophilized, and 
incubated under the appropriate conditions with 
purified thyroliberin deamidase [8]. Both HPLC 
and TLC (as in fig.1) showed that the major pro- 
duct was deamido-thyroliberin. The synthesis of 
thyroliberin from <GIu-His-Pro-Gly (using 
fraction 62) was not affected by the addition of 
either NH&l or glutamine precluding transamida- 
tion as a possible mechanism for the generation of 
the amide group. Furthermore, no thyroliberin 
was formed upon incubation of deamido- 
thyroliberin with either the acetone powder extract 
of secretory granules or partially purified prepara- 
tion (fraction 62, fig.2) in the presence of ATP, 
MgClz, and either NH&l or glutamine. Thus a 
direct amidation of the proline residue by 
mechanisms similar to those for the biosynthesis of 
glutamine and asparagine is considered unlikely. 
The characteristics of the amidating enzyme(s) 
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Fig.3. HPLC separation of reaction products: (A) 
Separation of thyroliberin (TRF) and <Glu-His-Pro-- 
Gly (TRF-Gly), 0.9 nmol each; (B) and (C) are 
representative HPLC runs of reaction products obtained 
when TRF-Gly (2.5~1 of a 2 mM solution) was 
incubated with 50~1 of either fraction 64 (24 h 
incubation) or fraction 62 (36 h incubation), 
respectively, from the gel filtration experiment described 
in fig.2; 10~1 aliquots of the assay mixture were 
analyzed. TRF-OH, deamido-thyroliberin. 
which converts the tetrapeptide to thyroliberin re- 
quires further study. The enzyme is presumably 
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similar to that studied in [2]. At present, there is 
scanty information regarding the biosynthetic 
precursors of thyroliberin [14]. In analogy with 
other peptide hormone precursors and consistent 
with the mechanism for amidation proposed in [2], 
we postulate that the thyroliberin precursor will in 
all likelihood contain a glycine residue subsequent 
to the tripeptide sequence. The mechanism of 
biosynthesis of the pyroglutamyl residue of 
thyroliberin is also not known. Model peptides of 
the type described here may aid in studies on this 
group. Our preliminary studies indicate that the 
post-mitochondrial 100000 x g particulate fraction 
from rat hypothalami can produce thyroliberin 
from <Glu-His-Pro-Gly. This fraction is, 
however, very active in degrading thyroliberin. 
Further studies are required on the characteristics 
of amidating enzyme(s) in hypothalamus which 
makes not only thyroliberin and luliberin but also 
the posterior pituitary hormones, vasopressin and 
oxytocin. 
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